Wright gets US nod for Allomatrix line:
This article was originally published in Clinica
Orthopaedic medical device company Wright Medical has gained US market clearance for its Allomatrix family of allograft bone void fillers. Following FDA clearance of its Allomatrix injectable putty in March this year, the company has now been given the go-ahead to sell its Allomatrix C, Allomatrix Custom, and Allomatrix DR bone graft putties that contain demineralised bone matrix (DBM) and specific volumes and configurations of donor matched, cancellous bone chips. The Arlington, Tennessee firm claims that its Allomatrix products and Osteoset 2 DBM bone graft substitute are the only commercially available, FDA-cleared products which contain DBM.
You may also be interested in...
GNC announces "significant" store and management staff furloughs and other cost-cutting moves "to protect the long-term prospects for the business." Vitamin Shoppe told customers that its stores remain open though it reduced business hours.
California-based biosensor patch company LifeSignals Group plans to file for an emergency use authorization from the US FDA for a new patch that can monitor vital signs to help individuals decide when to seek the help of a health care provider. See what LifeSignals’ CEO Surendar Magar said about it here.
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.